Dense deposit disease with steroid pulse therapy

Similar documents
RENAL HISTOPATHOLOGY

Long-term follow-up of juvenile acute nonproliferative glomerulitis (JANG)

A clinical syndrome, composed mainly of:

Case 3. ACCME/Disclosure. Laboratory results. Clinical history 4/13/2016

Familial DDD associated with a gain-of-function mutation in complement C3.

Atypical IgA Nephropathy

Steroid Resistant Nephrotic Syndrome. Sanjeev Gulati, Debashish Sengupta, Raj K. Sharma, Ajay Sharma, Ramesh K. Gupta*, Uttam Singh** and Amit Gupta

Case Presentation Turki Al-Hussain, MD

Dr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust

An unusual association between focal segmental sclerosis and lupus nephritis: a distinct concept from lupus podocytopathy?

Glomerular diseases mostly presenting with Nephritic syndrome

Overview of glomerular diseases

C1q nephropathy the Diverse Disease

Glomerular pathology-2 Nephritic syndrome. Dr. Nisreen Abu Shahin

Mayo Clinic/ RPS Consensus Report on Classification, Diagnosis, and Reporting of Glomerulonephritis

Glomerular Pathology- 1 Nephrotic Syndrome. Dr. Nisreen Abu Shahin

Renal Pathology 1: Glomerulus. With many thanks to Elizabeth Angus PhD for EM photographs

Clinicopathologic Characteristics of IgA Nephropathy with Steroid-responsive Nephrotic Syndrome

GOODPASTURE'S SYNDROME WITH CONCOMITANT IMMUNE COMPLEX MIXED MEMBRANOUS AND PROLIFERATIVE GLOMERULONEFRITIS

The CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of steroid therapy GUIDELINES

Ordering Physician. Collected REVISED REPORT. Performed. IgG IF, Renal MCR. Lambda IF, Renal MCR. C1q IF, Renal. MCR Albumin IF, Renal MCR

Monoclonal Gammopathies and the Kidney. Tibor Nádasdy, MD The Ohio State University, Columbus, OH

Membranoproliferative Glomerulonephritis

A Case of IgG2 Heavy Chain Deposition Disease in a Patient with Kappa Positive Plasma Cell Dyscrasia

ACUTE GLOMERULONEPHRITIS. IAP UG Teaching slides

Pathology of Complement Mediated Renal Disease

The CARI Guidelines Caring for Australasians with Renal Impairment

Surgical Pathology Report

THE URINARY SYSTEM. The cases we will cover are:

THE URINARY SYSTEM. The cases we will cover are:

A Case of Podocytic Infolding Glomerulopathy with Focal Segmental Glomerulosclerosis

RENAL EVENING SPECIALTY CONFERENCE

Interesting case seminar: Native kidneys Case Report:

Glomerular pathology in systemic disease

Histopathology: Glomerulonephritis and other renal pathology

CHAPTER 2. Primary Glomerulonephritis

Case Report A Case of Proliferative Glomerulonephritis with Monoclonal IgG Deposits That Showed Predominantly Membranous Features

The Sequential Development of Antiglomerular Basement Membrane Nephritis and Myeloperoxidase-antineutrophil Cytoplasmic Antibody-associated Vasculitis

Lab 3, case 1. Is this an example of nephrotic or nephritic syndrome? Why? Which portion of the nephron would you expect to be abnormal?

Glomerular Diseases. Anna Vinnikova, MD Nephrology

CHAPTER 2 PRIMARY GLOMERULONEPHRITIS

Glomerular diseases with organized deposits

Dr. Rai Muhammad Asghar Head of Paediatric Department BBH Rawalpindi

Coexistence of Anti-Glomerular Basement Membrane Glomerulonephritis and Membranous Nephropathy in a Female Patient with Preserved Renal Function

The CARI Guidelines Caring for Australasians with Renal Impairment. Idiopathic membranous nephropathy: use of other therapies GUIDELINES

Rejection or Not? Interhospital Renal Meeting 10 Oct Desmond Yap & Sydney Tang Queen Mary Hospital

Year 2004 Paper one: Questions supplied by Megan

Nephrotic syndrome in children. Bashir Admani KPA Nephrology Precongress 24/4/2018

Original. IgAN. Key words : IgA nephropathy, IgM deposition, proteinuria, tonsillectomy, steroid pulse therapy. Introduction

C3 GLOMERULOPATHIES. Budapest Nephrology School Zoltan Laszik

FIBRILLARY GLOMERULONEPHRITIS DIAGNOSTIC CRITERIA, PITFALLS, AND DIFFERENTIAL DIAGNOSIS

Clinicopathological analysis of proliferative glomerulonephritis with monoclonal IgG deposits in 5 renal allografts

Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report

C3 Glomerulopathy. Rezan Topaloglu, MD Hacettepe University School of Medicine Department of Pediatric Nephrology Ankara, TURKEY

Mr. I.K 58 years old

H enoch-schönlein purpura is a vasculitis with IgA

Thin basement membrane syndrome in adults

Current treatment recommendations in children with IgA nephropathy Selçuk Yüksel

Hemizygous Fabry disease associated with IgA nephropathy: A case report

Case # 2 3/27/2017. Disclosure of Relevant Financial Relationships. Clinical history. Clinical history. Laboratory findings

CASE 4 A RARE CASE OF INTRALUMINAL GLOMERULAR CAPILLARY DEPOSITS

Secondary IgA Nephropathy & HSP

Continuous Infusion of Cyclosporin A in Intravenous Immunoglobulin Resistant Kawasaki Disease Patients

C3G An Update What is C3 Glomerulopathy Anyway? Patrick D. Walker, M.D. Nephropath Little Rock, Arkansas USA

Clinical and pathological characteristics of patients with glomerular diseases at a university teaching hospital: 5-year prospective review

Hidden Tiger: An Atypical Presentation of Anti-Glomerular Basement Membrane Disease

CASE REPORT. Abstract. Introduction

Renal biopsy cases in myeloproliferative neoplasms (MPN)

Low-Density Lipoprotein Apheresis Therapy for Steroid- and Cyclosporine-Resistant Idiopathic Membranous Nephropathy

The improvement of renal survival with steroid pulse therapy in IgA nephropathy

Nephrotic Syndrome. Department of pediatrics The first affiliated hospital Sun Yat Sen University. Yue Zhihui ( 岳智慧 )

29 Glomerular disease: an overview

Nephrotic syndrome minimal change disease vs. IgA nephropathy. Hadar Meringer Internal medicine B Sheba

Case Presentation Turki Al-Hussain, MD

Xi Yang, Ri-Bao Wei, Ping Li, Yue Yang, Ting-Yu Su, Yu-Wei Gao, Qing-Ping Li, Xue-Guang Zhang, Xiang-Mei Chen

NEPHRITIC SYNDROME. By Dr Mai inbiek

Immune profile of IgA-dominant diffuse proliferative glomerulonephritis

C3 Glomerulonephritis versus C3 Glomerulopathies?

N. Hiramatsu, T. Kuroiwa, H. Ikeuchi, A. Maeshima, Y. Kaneko, K. Hiromura, K. Ueki and Y. Nojima

Glomerulonephritis. Dr Rodney Itaki Anatomical Pathology Discipline.

STEROID-RESISTANT NEPHROTIC SYNDROME (SRNS)

Dhanalakshmi.R II yr MD Stanley medical college

POST INFECTIOUS GLOMERULONEPHRITIS (PIGN) Anjali Gupta

Recurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab

Examination of the light microscopic slide of renal biopsy specimens by utilizing Low-vacuum scanning electron microscope

Dr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust

CASE 3 AN UNUSUAL CASE OF NEPHROTIC SYNDROME

Membranous nephropathy. By Mohammed Kamal Nassar, MD Lecturer of Nephrology Mansoura University

Keisuke Suzuki Naoto Miura Hirokazu Imai

Nephritic vs. Nephrotic Syndrome

Rituximab treatment for fibrillary glomerulonephritis

Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy

Pathogenesis of IgA Nephropathy. Shokoufeh Savaj MD Associate Professor of Medicine Firoozgar hospital- IUMS

Lupus Related Kidney Diseases. Jason Cobb MD Assistant Professor Renal Division Emory University School of Medicine October 14, 2017

Crescentic Glomerulonephritis (RPGN)

Journal of Nephropathology

Post-infectious (bacterial) Glomerulonephritis

Dr. Ghadeer Mokhtar Consultant pathologists and nephropathologist, KAU

Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report

Dense Deposit Disease in Korean Children: A Multicenter Clinicopathologic Study

Transcription:

Case Report Dense deposit disease with steroid pulse therapy Jun Odaka, Takahiro Kanai, Takane Ito, Takashi Saito, Jun Aoyagi, and Mariko Y Momoi Abstract Treatment of dense deposit disease DDD has not been established yet. Steroid therapy is considered as ineffective for DDD. We report an -year-old girl with DDD in whom steroid pulse therapy with subsequent oral steroid therapy led to disease remission. Serum C level improved in accordance with the amelioration of clinical signs. This case suggests that steroid pulse therapy with subsequent oral steroid therapy would be effective for some cases of DDD. Key words: C, Dense deposit disease, Remission, Steroid pulse therapy Background Treatment of dense deposit disease DDD has not been established yet: a half of the patients with DDD result in end-stage renal failure within years after the onset. Steroid therapy is considered as ineffective for DDD. We report an -year-old girl with DDD in whom steroid pulse therapy with subsequent oral steroid therapy led to disease remission. Case An -year-old girl, with no family history of renal disease, referred to us with gross hematuria. Physical examination revealed no edema but hollow cheek. Blood pressure and serum creatinine scr level were in the normal range in her age / mmhg and. mg/dl, respectively, although serum albumin, serum complement component C and complement % hemolytic titer CH levels had decreased to. g/dl, mg/dl normal range: - mg/dl and. U/ml normal range: - U/ ml, respectively. Total cholesterol level increased to mg/dl. Serum complement component C level was mg/dl normal range: - mg/dl, staying within normal range. Urine protein-creatinine Cr ratio was. g/g Cr. A renal biopsy revealed diffuse mesangial cell proliferation and mesangial matrix increase with all glomeruli showing double contours in a light microscope Figure A. There were no cellular or fibrous crescents in glomeruli detected. Immunostaining revealed granular C c deposits in the mesangial region Figure B and the glomerular basement membrane, but no IgG, IgA or IgM deposits. Electron microscopy revealed electron-dense deposits in the mesangial region and the lamina densa Figure C. We diagnosed this condition as idiopathic DDD. We excluded the secondary DDD by following data: antinuclear antibody, hepatitis B surface antigen, hepatitis C virus antibody were Department of Pediatrics, Jichi Children s Medical Center Tochigi, Jichi Medical University, Tochigi, Japan.

Steroid pulse therapy for DDD all negative. There are no established treatments for DDD. Steroid therapy is generally considered as ineffective for DDD. Some studies, however, showed a good response to steroid in patients with DDD who had few adverse prognostic factors clinically and histopathologically such as nephrotic or nephritic condition or cellular and/or fibrous crescent and tubular atrophy,. Therefore, we started steroid therapy, after obtaining informed consent from the patient and her parents. The patient received intravenous steroid pulse therapy methylprednisolone mpsl mg/kg/day three times per week: total doses mg/day x with subsequent oral prednisolone therapy PSL. - mg/kg/day for months. At eight months after the beginning of this steroid therapy, her proteinuria and hematuria disappeared, and serum C and CH levels increased to mg/dl and. U/ml, respectively, although serum C level never reached normal range. The PSL therapy was terminated at months after the beginning of this therapy, because she kept clinical remission. At months after the PSL termination, she developed proteinuria and hematuria again. Physical examination revealed no edema, normal blood pressure / mmhg but hollow cheek. Serum albumin and scr levels were in normal range. g/dl and. mg/ dl, respectively. Serum C and CH levels decreased to mg/dl and. U/ml, respectively. Urine protein-creatinine Cr ratio was. g/g Cr. A repeated renal biopsy revealed the same condition as before, showing no further deterioration. We started intravenous steroid pulse therapy mpsl mg/ day three times per week with subsequent oral prednisolone therapy PSL mg/day for four days for three weeks. Following eight weeks of oral PSL therapy, the dosage was maintained on an alternate day basis. At months after the beginning of the second treatment, urine protein-creatinine Cr ratio decreased to. g/g Cr and hematuria disappeared, and serum C and CH levels increased to mg/dl and. U/ml, respectively, although serum C level had not reached normal range Figure. Figure 1A. Initial renal biopsy Light microscopy revealed diffuse mesangial cell proliferation and mesangial matrix increase in all glomeruli. The arrow indicates a double contour of the glomerular basement membrane Periodic acid silvermethenamin PASM -Masson,. Figure 1B. Initial renal biopsy Immunofluorescence microscopy revealed granular C c deposits in the mesangial region.

Discussion We reported that steroid pulse therapy with subsequent oral steroid therapy was effective for this case with DDD in terms of an anti-proteinuric effect and C level improvement. Treatment of DDD has not been established yet. A randomized control study showed that steroid therapy was ineffective for DDD. However, the present case suggests that steroid pulse therapy with subsequent oral steroid therapy would be effective for some DDD cases. There are some reports that steroid therapy was effective for the cases with DDD when they had no adverse prognostic factors, similar to this case,. Although the mechanism of steroid effect for DDD remains unclear, steroid would correct the alternative complement pathway that forms the basic pathophysiology of DDD, considering that serum C level increased when proteinuria and hematuria disappeared. The relationship between serum C level and the clinical condition of DDD has not been elucidated. While some studies showed that serum C levels were not associated with the clinical condition of DDD, others showed that persistent hypocomplementemia was indicative of a poor prognosis. Iitaka et al. reported two cases in whom serum C levels were associated with clinical conditions of DDD. These two cases had increased serum C level along with the improvement of clinical condition in proteinuria and hematuria, of which course well accorded with that of the present case. Nasr et al. noted the heterogeneous nature of DDD, both clinically and pathologically. This heterogeneity has led to treatment dilemma. Now, classification based on the disease pathophysiology or clinical course may characterize such subgroups, which may eventually help to identify a subgroup in which steroid therapy may be effective. Thus, classification of DDD into some homogeneous subgroups Figure 1C. Initial renal biopsy Electron microscopy revealed electron-dense deposits in the mesangial region and along the lamina densa of the glomerular basement membrane. The arrow and arrowhead indicate the podocyte and electron-dense deposits, respectively. The star indicates the glomerular endothelial cell. Figure 2. Clinical course The arrows denote methylprednisolone pulse therapy. UP/UCr: urine protein/urine creatinine

Steroid pulse therapy for DDD may help to establish the treatment of this disease. In conclusion, this case report suggests steroid pulse therapy followed by oral steroid therapy would be considered for the cases with few adverse prognostic factors. Data accumulation is needed for establishing the treatment for DDD. References Appel GB, Cook HT, Hageman G, et al.: Membranoproliferative glomerulonephritis type dense deposit disease : An update. J Am Soc Nephrol : -,. Kim MS, Hwang PH, Kang MJ, et al.: A case of regression of atypical dense deposit disease without C deposition in a child. Korean J Pediatr : -,. Iitaka K, Nakamura S, Moriya S, et al.: Long-term follow-up of type membranoproliferative glomerulonephritis in two children. Clin Exp Nephrol : -,. Tarshish P, Bernstein J, Tobin JN, et al.: Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone--a report of the International Study of Kidney Disease in Children. Pediatr Nephrol : -,. Nasr SH, Valeri AM, Appel GB, et al.: Dense Deposit Disease: Clinicopathologic study of pediatric and adult patients. Clin J Am Soc Nephrol : -,.

Dense deposit disease 小高淳, 金井孝裕, 伊東岳峰, 齋藤貴志, 青柳順, 桃井真里子 要 約 Dense deposit disease DDD DDD C DDD DDD